Mig Capital, LLC Amgen Inc Transaction History

Mig Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $188,704 - $221,204	-1,132 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $204,744 - $230,792	1,132 New	1,132 $215,000
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $203,257 - $232,065	-1,215 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,215	1,215 $209,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mig Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Mig Capital, LLC with notifications on news.